Safety of sofosbuvir in patients with advanced kidney failure
Not Applicable
Completed
- Conditions
- Health Condition 1: B182- Chronic viral hepatitis C
- Registration Number
- CTRI/2019/03/018011
- Lead Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Patients with (i) hepatitis C virus infection with detectable HCV RNA in blood (ii) naïve to direct acting antiviral drugs based anti-HCV treatment
Exclusion Criteria
1. Hepatitis B virus co-infection
2. Human immunodeficiency virus co-infection
3. Clinical evidence of cirrhosis or portal hypertension such as ascites, esophageal or gastric varices on esophago-gastro-duodenoscopy, liver stiffness more than 15 KPa as measured with transient elastography or history of hepatic encephalopathy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method